Register or Sign in to Save this opportunity, or Send an Inquiry.
Anti-Tumor Therapy Using Mesenchymal Stem Cells as Targeting Vehicles for Suicide Genes Into Brain Tumors_Ajou Univ.
Korea Health Industry Development Institute (KHIDI) South Korea flag South Korea
Abstract ID:
A developed novel use of mesenchymal stem cells (MSCs) genetically modified to express a suicide gene for treating cancer
Send an Inquiry
RE:
Participants
You

GO PREMIUM TO GET PATENT INFORMATION
FEATURED
Last Updated Sep 2013
Technology Type THERAPEUTIC
Phase of Development EARLY STAGE
GOVERNMENT INSTITUTE

Opportunity Contact